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T-cell receptor mutation assay
Micronucleus test
Comet assay
Genetic polymorphismsLead is still widely used inmany industrial processes and is very persistent in the environment. Although toxic
effects caused by occupational exposure to lead have been extensively studied, there are still conflicting re-
sults regarding its genotoxicity. In a previous pilot study we observed some genotoxic effects in a population
of lead exposed workers. Thus, we extended our study analysing a larger population, increasing the number of
genotoxicity endpoints, and including a set of 20 genetic polymorphisms related to lead toxicokinetics and
DNA repair as susceptibility biomarkers. Our population comprised 148 workers from two Portuguese facto-
ries and 107 controls. The parameters analysed were: blood lead levels (BLL) and δ-aminolevulinic acid dehy-
dratase (ALAD) activity as exposure biomarkers, and T-cell receptor (TCR)mutation assay, micronucleus (MN)
test, comet assay and OGG1-modified comet assay as genotoxicity biomarkers. Lead exposed workers showed
markedly higher BLL and lower ALAD activity than the controls, and significant increases of TCR mutation
frequency (TCR-Mf), MN rate and DNA damage. Oxidative damage did not experience any significant alter-
ation in the exposed population. Besides, significant influencewas observed for VDR rs1544410 polymorphism
on BLL; APE1 rs1130409 and LIG4 rs1805388 polymorphisms on TCR-Mf; MUTYH rs3219489, XRCC4
rs28360135 and LIG4 rs1805388 polymorphisms on comet assay parameter; and OGG1 rs1052133 and
XRCC4 rs28360135 polymorphisms on oxidative damage. Our results showed genotoxic effects related to oc-
cupational lead exposure to levels under the Portuguese regulation limit of 70μg/dl. Moreover, a significant in-
fluence of polymorphisms in genes involved in DNA repair on genotoxicity biomarkers was observed.
© 2012 Elsevier Ltd. All rights reserved.cid dehydratase; ALADact, ac-
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rights reserved.1. Introduction
Although the toxic effect of lead has been known for centuries, it is
still widely used in many industrial processes that include mining,
household renovation, battery and automobile manufacturing, and
production of plastics, ceramics, paints and pigments that may in-
volve human exposure to this metal (Kasuba et al., 2010). Due to its
wide distribution and long persistence in the environment, exposure
to lead is a great hazard for human health. In fact, the International
Agency for Research on Cancer (IARC) classified it as possible human
carcinogen (group 2B) (IARC, 1987) and its inorganic compounds as
probable human carcinogens (group 2A) (IARC, 2006).
Adverse health effects caused by lead have long been recognized. It
is known that exposure to this heavy metal adversely affects human
health by producing toxicity in several organs and systems including
the cardiovascular, renal, immune and reproductive systems, as well
Table 1
Characteristics of the study population. P value refers to comparison between controls
and exposed, or between factory 1 and factory 2.




Time of exposure (years)a 19.54±0.94
Factory 1 15.9±10.9 b0.001c
Factory 2 25.0±10.1
Age (years)a 43.1±11.8 47.8±9.4 b0.001c
Factory 1 46.3±10.3 0.013c
Factory 2 50.2±7.3
Smokers 18 (16.8%) 60 (40.5%) b0.001b
Factory 1 42 (47.2%) 0.060b
Factory 2 18 (30.5%)
No. cigarettes/daya 14.9±11.1 19.5±11.7 0.146b
Factory 1 17.6±10.9 0.078c
Factory 2 23.8±12.5
a Mean±standard deviation.
b Fisher's exact test (two tail).
c Student's t-test (two tail).
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Cauli, 2009). Although toxic effects caused by occupational exposure
to lead have been extensively studied, there are still conflicting results
regarding its genotoxicity (reviewed in García-Lestón et al., 2010).
Several mechanisms have been suggested to be involved, such as in-
duction of cellular immunity and oxidative stress, inhibition of DNA
metabolism and repair, and formation of DNA and/or protein cross-
links (Mendez-Gomez et al., 2008).
In a previous study, we evaluated the genotoxic effects of occupa-
tional exposure to lead in a group of 70 Portuguese workers com-
pared with 38 controls. The results revealed a significant increase in
the mutation frequency of T-cell receptor (TCR) in the exposed indi-
viduals, and raised the possibility that some lifestyle factors could
influence the extent of damage (García-Lestón et al., 2011). Neverthe-
less, no modifications in DNA damage (evaluated by means of the
comet assay) were associated with the exposure, and no clear effect
was observed for vitamin D receptor (VDR) genetic polymorphism
on the parameters evaluated. Given these results, and the relevance
of genotoxic events for the outcome of cancer, since they are tightly
related to the first stages of carcinogenesis, we decided to extend
our study. With this aim, we analysed a larger population, increased
the number of genotoxicity endpoints, and included a set of genetic
polymorphisms related to lead toxicokinetics and DNA repair as sus-
ceptibility biomarkers.
Thus, we evaluated the genotoxic effects of occupational lead expo-
sure in a population of 148 workers from two Portuguese factories and
107 controls. The exposurewas evaluated by analysing blood lead levels
(BLL) and δ-aminolevulinic acid dehydratase (ALAD) activity. TCRmuta-
tion assay, micronucleus (MN) test, comet assay and OGG1-modified
comet assay, were performed to assess the genotoxicity. Besides, two
polymorphisms in genes involved in lead toxicokinetics (VDR and
ALAD), and 18 polymorphisms in genes involved in base excision repair
(BER) pathway (XRCC1, APE1, MUTYH, PARP1, MPG, PARP4, OGG1), non-
homologous end-joining (NHEJ) repair pathway (XRCC4, LIG4, XRCC5)
and homologous recombination (HR) repair pathway (XRCC2, XRCC3,
RAD51, NBS1) were genotyped as susceptibility biomarkers.
2. Materials and methods
2.1. Subjects and biological samples
Peripheral blood samples were obtained from 255 males and clas-
sified into two groups according to lead exposure. The first group
consisted of 148workers from two plants in Portugal that use inorgan-
ic lead in the workplace; plant 1 produce chemical substances and
plant 2 manufacture lead-acid batteries. The second one comprised
107 controls involved in administrative and commercial functions in
companies not using lead. Ethical approval from the National Institute
of Health Ethical Board and individual informed consents were
obtained. All the individuals participating in the study were asked to
complete a questionnaire whereby relevant information on age, life-
style factors (namely smoking and alcohol consumption habits),
health conditions, and occupational history was obtained. The charac-
teristics of the study population are shown in Table 1. In order to en-
sure a blind study, all samples were coded just after collection.
2.2. Blood lead levels
Blood lead levels (BLL) were determined in samples collected in
EDTA containers by electrothermal atomic absorption spectrometry
as described in García-Lestón et al. (2011).
2.3. ALAD activity
A standardized European method (Far Diagnostics, kit n°3602
(Berlin and Schaller, 1974)) was used to determine erythrocyteALAD activity. This parameterwas expressed as units ALAD/ml erythro-
cytes (1 U/ml corresponding to the substrate—5-aminolevulinate—
nanomoles transformed per minute and per erythrocytes ml). Analyses
were performed within 24 h of sampling because of ALAD instability.
2.4. Leukocyte isolation
BD VacutainerTM CPTTM Cell Preparation Tubes with sodium hepa-
rin (Becton Dickinson) were used for the isolation of mononuclear
leukocytes following manufacturer's instructions. Cells were used in
fresh for TCR mutation assay and MN test, or frozen for the comet
assay (standard and OGG1-modified). In this last case, they were sus-
pended in freezing medium (50% foetal calf serum, 40% RPMI 1640,
10% DMSO) to obtain 107cells/ml, and stored at−80 °C in a Nalgene®
Cryo 1 °C Freezing Container (Nalgene Nunc International), until the
time of analysis.
2.5. TCR mutation assay
TCRmutation assay was performed in duplicate by a flow cytometry
methodology followingAkiyama et al. (1995). Briefly,mononuclear leu-
kocytes were stained with 7-amino-actinomycin D to gate out dead
cells, and with fluorescein-isothiocyanate (FITC)-labeled anti-CD3 and
phycoerytrin (PE)-labeled anti-CD4 antibodies (Becton Dickinson). A
minimum of 2.5×105 lymphocyte gated events were acquired in a
FACSCalibur flow cytometer with Cell Quest Pro software (Becton
Dickinson). TCR mutation frequencies (TCR-Mf) were calculated as the
number of events in themutant cell window (CD3−CD4+ cells) divided
by the total number of events corresponding to CD4+ cells.
2.6. Flow cytometry micronucleus test
Determination of micronuclei (MN) frequency by flow cytometry
was performed following the protocol described by Valdiglesias et al.
(2011). For each duplicate sample a minimum of 50,000 events were
captured in a FACSCalibur flow cytometer (Becton Dickinson) from
the propidium iodide (PI) signal detected in the FL2 channel. Data anal-
ysiswas carried outwithCell Quest Pro software (BectonDickinson), fol-
lowing the instructions reported by Avlasevich et al. (2006).
2.7. Comet assay
After quickly thawing mononuclear leukocytes at 37 °C, cell viabil-
ity was assessed by trypan blue exclusion technique being, in all
cases, higher than 85%. The alkaline comet assay was performed as
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standard following Cebulska-Wasilewska (2003). A single scorer
examined 50 randomly selected cells per replicate slide (100 cells/
individual). Comet Assay IV software (Perceptive Instruments) was
used for image capture and analysis, considering the percentage of
DNA in the comet tail (%DNAT) as DNA damage parameter.
2.8. Oxidative damage
A variant of the comet assay introducing incubationwith the repair
enzyme OGG1 was used to evaluate the oxidative damage, following
the protocol proposed by Smith et al. (2006). Briefly, after lysis the
slides were washed 3 times 5 min each with a buffer containing
0.5 mM EDTA, 0.2 mg/ml BSA, 0.1 M KCl and 40 mM Hepes (pH 8).
Fifty microlitres of OGG1 (0.0016 U/μl buffer) were added to each
microgel. Immediately, gels were covered with a coverslip and incu-
bated in a humidified chamber for 10 min at 37 ° C. Four slides were
prepared from each individual. Two of them followed the treatment
with the enzyme and the other two were incubated only with 50 μl
of buffer, without enzyme. An internal standard was introduced as
described in Cebulska-Wasilewska (2003). After incubation, the cov-
erslips were removed and the slides underwent electrophoresis as de-
scribed in Laffon et al. (2002). The slides were examined as described
in the previous section. The oxidative damage (OGG1-sensitive sites)
was calculated as the difference between %DNAT in the enzyme-
incubated samples and the %DNAT in the buffer-incubated samples.
2.9. Genotyping
A commercially available kit (NucleoSpin® Blood L, Machery-Nagel)
was used to extract genomic DNA fromwhole blood samples according
to themanufacturer's instructions. DNA sampleswere stored at−20 °C
until analysis.
2.9.1. Genes involved in lead toxicokinetics
The genetic polymorphisms ofALAD (c.177 G>C, p.N59K, rs1800435)
and vitamin D receptor (VDR) (c.1024+283 G>A, rs1544410) were de-
termined by polymerase chain reaction-restriction fragment length poly-
morphism (PCR-RFLP) methods described in García-Lestón et al. (2011).
2.9.2. DNA repair genes
TheXRCC1 (c.580 C>T, p.R194W, rs1799782; c.1196G>A, p.R399Q,
rs25487), XRCC2 (c.563 G>A, p.R188H, rs3218536) and XRCC3 (c.722
C>T, p.T241M, rs861539) genetic polymorphisms were analysed by
PCR-RFLP as described in Silva et al. (2007) for XRCC1 polymorphisms,
and in Bastos et al. (2009) for XRCC2 and XRCC3 polymorphisms.
The following polymorphismswere genotyped by real-timePCRusing
TaqMan® SNP Genotyping Assays from Applied Biosystems (ABI Assays
references are indicated for each polymorphism) following Gomes et al.
(2010), Conde et al. (2009) and Silva et al. (2010): XRCC4 (c.894-
7 G>A, rs1805377, C_11685997_10; c.401 T>C, p.I134T, rs28360135,
C_25618660_10), LIG4 (c.26 C>T, p.T9I, rs1805388, C_11427969_20),
XRCC5 (c.2199*841 G>A, rs2440, C_3231046_20; c.2199*323 T>C,Table 2
Results obtained in the biomarkers of exposure and effect (mean±SE).
N Controls N Exposed
BLL (μg/dl) 107 3.65±0.41 148 32.00±1.
ALAD act. (U) 37 91.19±4.63 124 41.40±2.
TCR-Mf 107 6.86±0.97 91 21.06±1.
%MN 107 17.80±0.32 134 19.77±0.
%DNAT 106 3.75±0.19 138 5.72±1.
Ox. damage 106 1.39±0.24 138 1.59±0.
⁎⁎P≤0.01, ⁎P≤0.05, significant difference with regard to the control group.
#P≤0.05, significant difference with regard to factory 1.
SE: standard error.rs1051677, C_8838367_1; c.2199*451 A>G, rs1051685, C_8838368_1),
APE1 (c.444 T>G, p.D148E, rs1130409, C_8921503_10), MUTYH
(c.1005 C>G, p.Q335H, rs3219489, C_27504565_10), PARP1 (c.2285 T>
C, p.V762A, rs1136410, C_1515368_1), PARP4 (c.3982 C>A, p.P1328T,
rs1050112, C_8700142_10), MPG (c.49 A>C, p.K17Q, rs3176383, C_
32323403_10), OGG1 (c.977 C>G, p.S326C, rs1052133, C_3095552_1),
RAD51 (c.1-61 G>T, rs1801321, C_7482700_10) and NBS1 (c.553 G>C,
p.E185Q, rs1805794, C_26470398_10).
2.10. Statistical analysis
All analyses were performed using the SPSS for Windows statistical
package, version 18.0 (IL, USA). The statistical differences between
means and the relationship between categorical variables in the charac-
teristics of the study population were assessed bymeans of Student's t-
test and Fisher's exact test or Pearson's Chi-square test, respectively.
Analysis of variance (ANOVA) and Bonferroni's test were used to evalu-
ate the existence of differences among groups. The contribution of
potential confounding factors to the response variables considered
was analysed by multivariate analysis. Associations between variables
were assessed by Pearson's correlation. The level of statistical signifi-
cance was set at 0.05.
3. Results
This study comprised 255male individuals, 148 lead exposedworkers and 107 con-
trols. Results obtained for biomarkers of exposure and genotoxic effect are recorded in
Table 2. Regarding the biomarkers of exposure, lead exposedworkers showedmarkedly
higher BLL and lower ALAD activity than the controls; this last parameter was signifi-
cantly lower in workers from factory 1 than in those form factory 2. In the analysis of
genotoxicity biomarkers, significant increases of TCR mutation frequency (TCR-Mf),
MN rate and %DNAT were observed in the exposed group with regard to the controls.
Oxidative damage did not experience any significant alteration in the exposed popula-
tion, but workers from plant 2 presented significantly lower values than those from
plant 1.
Multivariant analyses were applied to determine the possible associations between
the biomarkers evaluated and lifestyle factors (tobacco consumption and age), and re-
sults obtained are summarized in Table 3. Smoking did not influence any variable, and a
significant effect of age was only observed on BLL. Indeed, significant correlation was
obtained between age and BLL (r=0.266, Pb0.01), and also between age and ALAD ac-
tivity (r=−0.372, Pb0.01), TCR-Mf (r=0.153, Pb0.05), and MN frequency (r=0.160,
Pb0.05).
In the evaluation of the relationships between the analytical variables assessed, BLL
were positively correlatedwith TCR-Mf (r=0.381, Pb0.01), %DNAT (r=0.230, Pb0.01)
and MN frequency (r=0.206, Pb0.01), and inversely correlated with ALAD activity
(r=−0.491, Pb0.01). ALAD activity was also inversely correlated with TCR-Mf (r=
− 0.191, Pb0.05) and MN frequency (r=−0.378, Pb0.01). Finally, %DNAT was posi-
tively correlated with TCR-Mf (r=0.295, Pb0.01).
Twenty single nucleotide polymorphisms were determined in this study; Tables 4
and 5 gather the genotype frequencies in the study populations for the 2 genes in-
volved in the toxicokinetics of lead and for the 14 DNA repair genes, respectively. Sig-
nificant differences were observed in the genotype distribution of ALAD rs1800435,
OGG1 rs1052133 and XRCC5 rs1051677 polymorphisms between exposed population
and control group. However, it must be taken into account that for the XRCC5
rs1051677 polymorphism the p value obtained is not accurate since the genotype C/C
has no representation in the study population. The frequencies of the variant allele in
all the polymorphisms were equivalent to those found in the single nucleotide poly-
morphisms (SNP) database from NCBI (National Center for Biotechnology Information)
except for VDR rs1544410 (0.508 vs. 0.267), XRCC1 rs25487 (0.334 vs. 0.266), MUTYHN Factory 1 N Factory 2
09⁎⁎ 89 30.50±1.22⁎ 59 34.26±1.99⁎
28⁎⁎ 79 35.58±2.51⁎ 45 51.62±4.07⁎,#
85⁎⁎ 49 20.76±2.47⁎ 42 21.41±2.83⁎
28⁎⁎ 79 19.67±0.30⁎ 55 19.92±0.54⁎
85⁎⁎ 82 5.69±0.39⁎ 56 5.76±0.35⁎
27 82 2.10±0.32 56 0.83±0.44#
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95% CI Partiala R2 Modelb
P value P value
1. BLL (μg/dl)
Age (years) 0.154 0.032 to 0.276 0.014 0.653 b0.001
Smokers vs.
non-smokers
0.420 −2.474 to 3.314 0.775 0.644 b0.001
2. ALAD act. (U)
Age (years) −0.140 −0.606 to 0.327 0.555 0.398 b0.001
Smokers vs.
non-smokers
1.044 −7.598 to 9.686 0.812 0.397 b0.001
3. TCR-Mf
Age (years) 0.078 −0.106 to 0.263 0.404 0.206 b0.001
Smokers vs.
non-smokers
4.000 −0.550 to 8.550 0.085 0.215 b0.001
4. %MN
Age (years) 0.032 −0.008 to 0.072 0.112 0.093 b0.001
Smokers vs.
non-smokers
0.573 −0.359 to 1.505 0.227 0.088 b0.001
5. %DNAT
Age (years) 0.007 −0.027 to 0.040 0.693 0.115 b0.001
Smokers vs.
non-smokers
0.370 −0.404 to 1.145 0.347 0.118 b0.001
5. Ox. damage
Age (years) −0.016 −0.051 to 0.019 0.394 0.005 0.578
Smokers vs.
non-smokers
0.417 −0.400 to 1.235 0.316 0.005 0.528
a Significance of the particular variable (age or smoking) on the response variable.
b Significance of the model applied.
Table 5








BER XRCC1 rs1799782 C/C 70 (84.3) 116 (78.4) 0.540
C/T 12 (14.5) 29 (19.6)
T/T 1 (1.2) 3 (2)
Variant allele frequency 0.085 0.118
XRCC1 rs25487 G/G 35 (42.2) 68 (45.9) 0.728
G/A 37 (44.6) 65 (43.9)
A/A 11 (13.3) 15 (10.1)
Variant allele frequency 0.356 0.321
APE1 rs1130409 T/T 27 (32.5) 40 (27.2) 0.251
T/G 37 (44.6) 82 (55.8)
G/G 19 (22.9) 25 (17)
Variant allele frequency 0.452 0.449
MUTYH rs3219489 C/C 44 (53) 80 (54.1) 0.491
C/G 34 (41) 53 (35.8)
G/G 5 (6) 15 (10.1)
Variant allele frequency 0.265 0.280
PARP1 rs1136410 T/T 55 (66.3) 110 (75.3) 0.327
T/C 26 (31.3) 34 (23.3)
C/C 2 (2.4) 2 (1.4)
Variant allele frequency 0.181 0.131
PARP4 rs1050112 C/C 30 (36.1) 62 (42.2) 0.335
C/A 40 (48.2) 71 (48.3)
A/A 13 (15.7) 14 (9.5)
Variant allele frequency 0.398 0.337
MPG rs3176383 A/A 83 (100) 146 (100)
A/C 0 0
C/C 0 0
Variant allele frequency 0 0
OGG1 rs1052133 C/C 55 (66.3) 83 (56.5) 0.036
C/G 28 (33.7) 54 (36.7)
G/G 0 10 (6.8)
Variant allele frequency 0.169 0.252
NHEJ XRCC4 rs28360135 T/T 75 (90.4) 132 (89.2) 0.747
T/C 8 (9.6) 15 (10.1)
C/C 0 1 (0.7)
Variant allele frequency 0.048 0.575
XRCC4 rs1805377 G/G 67 (80.7) 108 (74) 0.086
G/A 16 (19.3) 30 (20.5)
A/A 0 8 (5.5)
Variant allele frequency 0.097 0.158
LIG4 rs1805388 C/C 64 (77.1) 113 (76.4) 0.964
C/T 17 (20.5) 32 (21.6)
T/T 2 (2.4) 3 (2)
Variant allele frequency 0.127 0.128
XRCC5 rs2440 G/G 26 (18.1) 35 (23.6) 0.415
G/A 41 (49.4) 78 (52.7)
A/A 16 (32.5) 35 (23.6)
Variant allele frequency 0.572 0.500
XRCC5 rs1051677 T/T 76 (91.6) 114 (77) 0.006
T/C 7 (8.4) 34 (23)
C/C 0 0
Variant allele frequency 0.042 0.115
XRCC5 rs1051685 A/A 64 (77.1) 120 (81.8) 0.745
A/G 18 (21.7) 26 (16.9)
G/G 1 (1.2) 2 (1.4)
Variant allele frequency 0.121 0.100
HR XRCC2 rs3218536 G/G 66 (15.7) 128 (86.5) 0.199
G/A 16 (19.3) 20 (13.5)
32 J. García-Lestón et al. / Environment International 43 (2012) 29–36rs3219489 (0.276 vs. 0.319), PARP1 rs1136410 (0.148 vs. 0.244), XRCC2 rs3218536
(0.118 vs. 0.043), XRCC3 rs861539 (0.448 vs. 0.251), RAD51 rs1801321 (0.503 vs.
0.265), XRCC4 rs28360135 (0.054 vs. 0.016), XRCC4 rs1805377 (0.136 vs. 0.393) and
XRCC5 rs1051677 (0.089 vs. 0.125).
The possible influence of the polymorphisms in lead toxicokinetics genes was in-
vestigated in both exposure and genotoxic effect biomarkers; for DNA repair genes,
this influence was only assessed in genotoxicity biomarkers. All the exposed and con-
trol individuals were wild-type homozygous for MPG rs3176383 polymorphism, so it
could not be included in the evaluation. Due to the large amount of data generated
in these analyses, only statistically significant results are shown in Table 6. None of
the exposure or genotoxicity biomarkers were significantly influenced by polymor-
phisms in ALAD, XRCC1, APE1, PARP1, XRCC5, XRCC2, XRCC3, RAD51 or NBS genes. VDR
rs1544410 polymorphism influenced BLL, since carriers of the variant allele B showed
lower BLL than wild-type b homozygotes, although significance was only reached for
B/B homozygotes. The presence of the G variant allele of APE1 rs1130409 was associat-
ed with an increase in TCR-Mf, significant only in G/G homozygous individuals. LIG4
rs1805388 polymorphism influenced both TCR-Mf and %DNAT, significantly only in
T/T homozygotes, which showed higher values of the genotoxicity parameters than
wild-type C/C homozygous individuals. Individuals who carry the MUTYH rs3219489
G variant allele displayed higher levels of DNA damage than wild-type C/C homozy-
gotes; the difference was significant for the comparison with heterozygous subjects.
The same influence on DNA damage was observed in XRCC4 rs28360135 C variant
allele carriers, although in this case the significance was obtained in C/C homozygous
individuals. Besides, XRCC4 rs28360135 polymorphism was also associated with a
decrease in oxidative damage in C allele carriers, significant only in homozygous indi-
viduals. Oxidative damage was also influenced by OGG1 rs1052133, as individuals car-
rying G variant allele presented higher damage than C/C homozygotes; significance
was reached only in G/G homozygous individuals.Table 4
Genotype distribution of genes involved in lead toxicokinetics in control and exposed
groups.
SNP Genotype Controls N (%) Exposed N (%) P valuea
VDR rs1544410 b/b 33 (32.0) 40 (27.0) 0.540
B/b 42 (40.8) 59 (39.9)
B/B 28 (27.2) 49 (33.1)
Variant allele frequency 0.476 0.531
ALAD rs1800435 1/1 85 (86.7) 127 (96.2) 0.003
1/2 13 (13.3) 3 (2.3)
2/2 0 2 (1.5)
Variant allele frequency 0.067 0.027
a Pearson's Chi-square (two tail).
A/A 1 (65.1) 0
Variant allele frequency 0.254 0.068
XRCC3 rs861539 C/C 24 (28.9) 49 (33.3) 0.770
C/T 40 (48.2) 68 (46.3)
T/T 19 (22.9) 30 (20.4)
Variant allele frequency 0.470 0.436
RAD51 rs1801321 G/G 26 (26.5) 36 (23.6) 0.473
G/T 37 (44.6) 69 (46.6)
T/T 20 (28.9) 43 (29.7)
Variant allele frequency 0.512 0.530
NBS1 rs1805794 G/G 36 (43.4) 67 (45.3) 0.895
G/C 37 (44.6) 66 (44.6)
C/C 10 (12) 15 (10.1)
Variant allele frequency 0.343 0.324
a Pearson's Chi-square (two tail).
Table 6








VDR rs1544410 B/b vs. b/b −0.683 −3.801 to 2.435 0.667 0.662 b0.001
B/B vs. b/b −4.444 −7.763 to −1.125 0.009
2. TCR-Mf
APE1 rs1130409 T/G vs.T/T 1.135 −3.896 to 6.167 0.657 0.237 b0.001
G/G vs. T/T 7.864 1.314 to 14.414 0.019
LIG4 rs1805388 C/T vs. C/C 4.603 −0.929 to 10.136 0.102 0.259 b0.001
T/T vs. C/C 20.787 7.867 to 33.707 0.002
3. %DNAT
MUTYH rs3219489 C/G vs. C/C 1.255 0.467 to 2.044 0.002 0.160 b0.001
G/G vs. C/C 1.103 −0.273 to 2.480 0.115
XRCC4 rs28360135 C/T vs. T/T 0.588 −0.643 to 1.819 0.348 0.149 b0.001
C/C vs. T/T 7.346 1.852 to 12.839 0.009
LIG4 rs1805388 C/T vs. C/C −0.530 −1.444 to 0.385 0.255 0.151 b0.001
T/T vs. C/C 3.155 0.674 to 5.637 0.013
4. Ox. damage
OGG1 rs1052133 C/G vs. C/C 0.123 −0.692 to 0.938 0.766 0.065 0.014
G/G vs. C/C 3.379 1.479 to 5.279 0.001
XRCC4 rs28360135 C/T vs. T/T −0.830 −2.094 to 0.434 0.197 0.088 0.001
C/C vs. T/T −11.743 −17.383 to −6.103 0.000
a Significance of the particular comparison between genotypes.
b Significance of the model applied.
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than one genetic polymorphism, we calculated a categorical variable by grouping the
subjects according to the number of variant alleles in each group of genes that showed
a significant influence on each genotoxicity parameter, in order to test if they may have
a combined effect, and the results are gathered in Table 7. The increase in the number of
variant alleles of APE1 rs1130409 and LIG4 rs1805388 polymorphisms was associated
with an increase in TCR-Mf, significant in the group of individuals with 3 or more
variant alleles. %DNAT also increased with the number of variant alleles of MUTYH
rs3219489, XRCC4 rs28360135 and LIG4 rs1805388 polymorphisms; significance was
reached in all subjects with more than 1 variant allele. Besides, an increase in the oxida-
tive damage was observed in individuals carrying 2 variant alleles of OGG1 rs1052133,
and XRCC4 rs28360135 polymorphisms, but in this case themodel did not reach the sta-
tistical significance.
4. Discussion
In this study we evaluated the genotoxic effects of lead exposure in
a population of 148 workers from two Portuguese factories, and com-
pared them with 107 controls. Lead exposure was assessed by means
of BLL and ALAD activity, since they are the most widely used and re-
liable biomarkers of lead exposure (Sakai, 2000). BLL showed a 9-fold
increase in the exposed workers with regard to the controls. Although
none of the exposed individuals exceeded the 70 μg/dl limit estab-
lished by the Portuguese regulation, 47 exposed workers (32%) went
over the US Occupational Safety and Health Administration (OSHA)
limit (40 μg/dl). Contrary to BLL, and according to the strong ALAD
inhibitory role of lead, a significant decrease in ALAD activity wasTable 7
Influence of the number of variant alleles of DNA repair genes on genotoxicity biomarkers.
Model No. of variant
alleles (N)
1. TCR-Mf
APE1 rs1130409 and LIG4 rs1805388 1 (79) vs. 0 (43)
2 (40) vs. 0 (43)
≥3 (11) vs. 0 (43)
2. %DNAT
MUTYH rs3219489, XRCC4 rs28360135 and LIG4 rs1805388 1 (97) vs. 0 (79)
2 (33) vs. 0 (79)
≥3 (10) vs. 0 (79)
3. Ox. damage
OGG1 rs1052133 and XRCC4 rs28360135 1 (89) vs. 0 (113)
2 (16) vs. 0 (113)
a Significance of the particular comparison between genotypes.
b Significance of the model applied.observed in the exposed group when compared to the controls; in-
deed, ALAD activity and BLL were negatively correlated. Moreover,
workers from factory 2 showed significantly higher ALAD activity
than those from factory 1, probably due to the different activities de-
veloped in the two factories.
We did notfind relationship between BLL and timeworking in a lead
contaminated environment. Indeed, BLL are not cumulative; they re-
flect the exposure occurred only during the last weeks (Schwartz et
al., 1994). However, BLL were significantly and positively influenced
by age, suggestingmodifications in lead toxicokinetics that entail higher
BLL with increasing age under a given exposure level.
In order to evaluate comprehensively the possible genotoxic ef-
fects of occupational exposure to lead, we analysed four different gen-
otoxicity biomarkers (TCR mutation assay, MN test, comet assay, and
oxidative damage as OGG1 sensitive sites in the comet assay), since
they can reflect different mechanisms of damage induction. Our data
showed significant increases in TCR-Mf, MN frequency and primary
DNA damage in the lead exposed workers, confirming the genotoxi-
city associated with this occupational exposure, not only in the short
term (comet assay results) but also in the medium-long term (TCR
mutation assay and MN test). Moreover, all these 3 parameters were
significantly correlated with BLL. These results generally agree with
most studies that evaluated genotoxicity parameters (comet assay, MN
test, chromosomal aberrations) in people occupationally exposed to







0.686 −4.632 to 6.01 0.799 0.284 b0.001
4.479 −1.746 to 10.71 0.157
18.535 9.07 to 28.00 0.000
0.400 −0.420 to 1.220 0.338 0.149 b0.001
1.184 0.063 to 2.305 0.038
1.999 0.182 to 3.817 0.031
−0.196 0.989 to 0.597 0.627 0.041 0.113
1.819 0.313 to 3.324 0.018
34 J. García-Lestón et al. / Environment International 43 (2012) 29–36our population (Grover et al., 2010; Kasuba et al., 2010; Khan et al.,
2010; and previous works reviewed in García-Lestón et al., 2010).
Thus, all these data indicate that lead exposure in theworkplace induces
mutagenicity, chromosomal alterations andDNAdamage (strandbreaks
and/or alkali-labile sites). In this study the origin of the MN observed
was not investigated, but results fromPalus et al. (2003), who combined
MN test with fluorescence in situ hybridization (FISH) with pan-
centromeric probes, showed that the increase in the MN frequency in
workers from a battery plant, mainly exposed to lead, was due to clasto-
genic as well as aneugenic effects. The negative results obtained in our
previous study regarding comet assay (García-Lestón et al., 2011), and
in the only previous study which evaluated TCR-Mf in a population of
lead exposed workers (Chen et al., 2006), are probably explained by
the lower sample sizes (70 and 25 exposed individuals, respectively).
As far as we know, the current study comprises the largest group of
lead exposed workers analysed for genotoxicity.
Nevertheless, we did not observe differences in the oxidative DNA
damage between exposed and control individuals. Previous studies
that assessed oxidative stress in workers exposed to lead reported pos-
itive results (Ergurhan-Ilhan et al., 2008; Gurer-Orhan et al., 2004; Ye
et al., 1999). Parameters analysed in these studies were concentration
of malondialdehyde (MDA), alpha-tocopherol, beta-carotene, glutathi-
one:glutathione disulfide ratio, and activity of enzymes like superoxide
dismutase (SOD), glucose-6-phosphate dehydrogenase (G6PD), cata-
lase and glutathione peroxidase (GPx). Incorporating incubation with
OGG1 in the comet assay, we determined the presence of 8-oxo-7,8-
dihydroguanine (8-oxoGua), the main result of oxidative DNA damage
(Angerer et al., 2007) and one of the most abundant and highly muta-
genic base lesions (Laantri et al., 2011). Therefore, it seems that the
oxidative stress induced by lead exposure causes lipid peroxidation, de-
pletion of antioxidants, and increase in antioxidant enzyme activities
but, according to our results, it does not affect the geneticmaterial. Nev-
ertheless, despite no significant differences observed in the exposed
workers regarding to controls, our results showed a significant differ-
ence in oxidative DNA damage between the two plants, being higher
in plant 1 regarding to plant 2. This suggests that the type of activity
developed in plant 1 involves, in addition to larger decrease in ALAD ac-
tivity, higher risk of induction of oxidative DNA damage.
Although the influence of age on both TCR-Mf andMN frequencywas
previously reported and even quantified (Akiyama et al., 1995; Bonassi
et al., 2001), our results of themultivariate analysis did not showany sig-
nificant influence for this factor even though the age range covered by
our study group was wide (21–67). Nevertheless, slight but significant
positive correlations were obtained between age and the two genotoxi-
city parameters.
Vitamin D receptor (VDR) plays a major role in maintaining calcium
and phosphate homeostasis, in regulating bone metabolism, and is also
involved in anti-proliferative, pro-apoptotic and immunosuppressive
activities (Hendy et al., 2006). Schwartz et al. (2000) reported that
VDR B allele carriers for the rs1544410 polymorphism have higher BLL
and bone lead content than subjects with bb genotype. On the contrary,
our results showed significantly lower BLL in BB individuals. However,
Schwartz et al. analyzed together all individuals carrying B allele
(bB+BB), and they included among the lead exposedworkers anunde-
termined number of retired workers, who are supposed to have ceased
their exposure to lead some time ago. These facts might help to explain
these different results. Besides, linkage disequilibrium of this probably
non-functional VDR polymorphism (it is located in intron 8) with one
or more truly functional polymorphisms elsewhere in the VDR gene
was suggested (Uitterlinden et al., 2004).
The human APE1 gene encodes the major apurinic/apyrimidinic
(AP) endonuclease in mammalian cells (APE1) that plays a central
role in BER pathway by hydrolyzing the phosphodiester backbone im-
mediately 5′ to AP sites in DNA. These AP sites constitute cytotoxic
and mutagenic lesions that can prevent normal DNA replication if
unrepaired (Cao et al., 2011). Two studies using X-ray crystallographyand nuclear magnetic resonance spectroscopy observed that lead may
occupy two potential divalent metal binding sites within the APE1 ac-
tive site, disrupting the magnesium-dependent catalytic reaction that
is essential for enzymatic activity (Beernink et al., 2001; Lowry et al.,
2003). Moreover, McNeill et al. (2004) reported that lead inhibits
APE1 incision activity in vitro, and thus suggested that lead can elicit
its mutagenic effects in part by inactivating APE1 repair activities. Al-
though APE1 rs1130409 polymorphism has no impact on DNA binding
capacity or endonuclease activity of the protein (Hadi et al., 2000), the
overall results of a recent meta-analysis performed by Gu et al. (2009)
indicated that the variant APE1 rs1130409 genotypes were associated
with a moderately increased risk of all cancer types. Similarly, in the
current study we observed higher levels of TCR-Mf in APE1 rs1130409
G allele carriers. As a hypothesis, maybe lead substitutes magnesium
more efficiently in the protein encoded by this allele, so it is more sus-
ceptible to be inhibited by lead in exposed individuals.
The human MUTYH gene encodes a DNA glycosylase that excises
adenine bases from DNA backbone at sites where adenine is inappro-
priately paired with guanine, cytosine, or 8-oxoGua (Wilson et al.,
2011). Our results showed higher levels of DNA damage related to
the presence of MUTYH rs3219489 variant allele G, what is in agree-
ment with a study donewith human lymphocytes exposed to glycida-
mide (Pingarilho et al., submitted). However, in our study the higher
levels of DNA damage were only obtained for the C/G heterozygotes,
possibly due the small representation of the G/G homozygous geno-
type in the whole population. In other studies, no association between
MUTYH rs3219489 polymorphism and breast cancer risk (Conde et al.,
2009) or non-small cell lung cancer risk (Qian et al., 2010)was reported.
The human 8-oxo-guanine glycosylase 1 (OGG1) gene encodes a
protein responsible for the cleavage of 8-oxoGua, a major form of base
lesion produced by oxidative damage to DNA. If this lesion is not ex-
cised, it can bematchedwith adenine leading to aGC to TA transversion.
Therefore, decreased function of OGG1 could lead to mutations that ac-
tivate oncogenes or inactive tumour suppressor genes (Laantri et al.,
2011; Roberts et al., 2011). The OGG1 rs1052133 variant protein has
been reported to have a lower ability to prevent mutagenesis
(Yamane et al., 2004), supporting the results of association studies
that G is a risk allele for several types of human cancer, including pros-
tate (Chen et al., 2003), lung (Kohno et al., 2006), gastric (Farinati et al.,
2008), and head and neck (Kumar et al., 2011). On the contrary, other
studies did not find any association between this polymorphism and
risk of breast cancer (Roberts et al., 2011), thyroid cancer (García-
Quispes et al., 2011) or nasopharyngeal cancer (Laantri et al., 2011).
Results of our study showed a significant increase of oxidative
damage in homozygous individuals for the OGG1 rs1052133 G variant
allele, suggesting a less effective repair of 8-oxoGua DNA lesions.
According to this, Hill and Evans (2006) reported altered substrate
specificity, lack of stimulation by APE1 and anomalous DNA binding
conformation for the variant enzyme OGG1. Moreover, Bravard et al.
(2009) observed that cells homozygous for the G variant allele display
reduced in vivo 8-oxoGua repair rates, and also their OGG1 activity is
more sensitive to inactivation by oxidizing agents, suggesting that ho-
mozygous individuals for the variant allele could accumulate more
mutations under conditions of oxidative stress.
XRCC4 and LIG4 genes encode two proteins that form a complex in-
volved in the alignment and rejoining of DNA ends in the final step of
NHEJ, the major pathway used by human cells to repair DNA double
strand breaks (Wu et al., 2009). Any amino acid exchange that results
in diminished stability of this complex could result in a lower activity
and consequently a defect in the DNA repair (Gomes et al., 2010). Pre-
vious studies investigating the association between XRCC4 or LIG4
polymorphisms and risk of different cancer types reported negative
(Gomes et al., 2010; Roddam et al., 2002) and positive (Figueroa et
al., 2007; Tseng et al., 2009;Werbrouck et al., 2008) results. In the cur-
rent work homozygous variant allele carriers of LIG4 rs1805388 (T/T)
or XRCC4 rs28360135 (C/C) polymorphisms showed higher values of
35J. García-Lestón et al. / Environment International 43 (2012) 29–36TCR-Mf (LIG4 rs1805388 polymorphism) and DNA damage (both
polymorphisms), suggesting a possible relationship between the pres-
ence of the variant alleles and a less effective DNA repair activity. Nev-
ertheless, the presence of the XRCC4 rs28360135 C variant allele was
associated with a lower level of oxidative DNA damage. The meaning
of this result is somewhat conflicting, since the main oxidative DNA
lesion detected (8-oxoGua) is preferentially repaired by the BER path-
way and not by NHEJ (Robertson et al., 2009).
Apart from the differences observed in the levels of TCR-Mf, %DNAT
and oxidative damage related to single DNA repair gene polymor-
phisms, we also found that the increasing number of variant alleles of
APE1 rs1130409 and LIG4 rs1805388 polymorphisms was associated
with an increase in TCR-Mf, and the same occurred for MUTYH
rs3219489, XRCC4 rs28360135 and LIG4 rs1805388 polymorphisms
with regard to %TDNA. The simultaneous involvement of two or more
polymorphic genes in the levels of genotoxic damage denotes the
importance of the simultaneous evaluation of multiple polymorphic
genes related with DNA repair processes for a more precise assessment
of the individual susceptibility to different types of DNA lesions. How-
ever, the combined effect of OGG1 rs1052133 and XRCC4 rs28360135
polymorphisms obtained on oxidative damage has no plausibility,
since the effect of each single variant allele on the genotoxicity param-
eter was opposite, and also the multivariate model was not significant.
In summary, these results showed genotoxic effects related to occu-
pational lead exposure to levels under the limit of 70 μg/dl established
by the Portuguese regulation, confirming our previous results (García-
Lestón et al., 2011). Therefore, we reaffirm the recommendation of re-
ducing the threshold limit for BLL in the Portuguese regulation in order
to preserve workers’ safety; a limit b20 μg/dl, even lower than OSHA
limit (40 μg/dl), was already indicated by Schwartz and Hu (2007). Be-
sides, significant influences of VDR gene polymorphism on BLL, and of
polymorphisms in genes involved in BER and NHEJ, but not in HR, on
genotoxicity biomarkerswere observed, suggesting a role for DNA repair
gene polymorphisms as susceptibility biomarkers in occupational geno-
toxicity biomonitoring.
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